Life Care Plans &
Medical Necessity
Overview
Personal injury and malpractice cases increasingly feature damages in the form of expected future care, life care plans, (“LCPs”) and related forms of future losses (for example, earnings or hedonic damages). There are five main limitations to the typical LCP: (1) dollar amounts reflect expected charges, not reasonable value; (2) some services may not be medically necessary and would benefit from an independent review of necessity; (3) some non-medical services, like attendant care, may be incorrectly valued; (4) estimates of life expectancy (“LE”) may be incorrect or may fail to account for preexisting conditions known to decrease LE; and (5) inflation and net present value (“NPV”) may not be properly accounted for. Avalon has a team who can provide insights on all these tasks, determining reasonable value and medical necessity. Our clinical team can also develop LCPs that take into consideration reasonable value and medical necessity.
Types Of Engagements
- Reasonable value of life care plans in personal injury cases
- Calculation of future Medicare, Medicaid, workers’ compensation, and Personal Injury Protection (PIP) payments
- Development of life care plans in a personal injury cases
- Assessment of medical necessity in life care plans
- Calculation of life expectancy based on pre-existing comorbid conditions
- Cost parameter estimates for future care in cost impact, budget impact, and cost-effectiveness models
Reasonable Value of Medical Charges
Key Staff
- John Schneider, PhD
- Cara Scheibling, MBA
- Anna Whelan, BA
- Laura Bellmont, MPAS
Related Markets & Industries
- Insurance & third-party payers
- Attorneys & law firms
- Medical services
- Hospitals & health systems
- Utilities
- Construction
- Transportation
Related Publications
- Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. 2021
- Mendelian randomization: estimation of inpatient hospital costs attributable to obesity. 2021
- The Economics of Reasonable Value and the Valuation of Medical Losses. 2019
- What is the Reasonable Value of Future Medical Care? 2019
- Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease 2017
- Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study 2017
- Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer 2016
- Hospital Expenditure at the End-of-Life: What Are the Impacts of Health Status and Health Risks? 2015
- Projecting long-term graft and patient survival after transplantation. 2014
- Population ageing and healthcare expenditure projections: new evidence from a time to death approach. 2013
- A patient-centered approach to estimate total annual healthcare cost by body mass index in the UK Counterweight program. 2013
Related Issue Briefs
- What are “Hedonic Damages,” and Should They Matter in Litigation? (Issue Brief No. 56)
- The Rise of Litigation Funding and Medical Funding in Personal Injury and Product Liability Lawsuits (Issue Brief No. 54)
- Electronic Medical Records: Potential Issues in Litigation and Biomedical Research (Issue Brief No. 48)
- What is the Reasonable Value of Future Medical Care? (Issue Brief No. 44)
- U.S. Health Care Costs: Disentangling Underlying Trends from the Effects of the Affordable Care Act (Issue Brief No. 8)
- Nobody Pays Retail: A Primer on Valuing Medical Care Bills (Issue Brief No. 2)
- Using Publicly Available Health Care Databases to Value & Price Medical Care Services (Issue Brief No. 1)